Hubei Biocause Heilen Pharmaceutical Co., Ltd. (SHE:301211)
China · Delayed Price · Currency is CNY 12.81
+0.07 (0.55%)
Feb 4, 2026, 1:35 PM CST
SHE:301211 Market Cap
SHE:301211 has a market cap or net worth of 5.32 billion as of February 3, 2026. Its market cap has decreased by -13.48% in one year.
Market Cap
5.32B
Enterprise Value
3.75B
Revenue
430.77M
Ranking
n/a
PE Ratio
140.71
Stock Price
12.81
Market Cap Chart
Since December 22, 2021, SHE:301211's market cap has decreased from 8.96B to 5.32B, a decrease of -40.60%. That is a compound annual growth rate of -11.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 3, 2026 | 5.32B | 4.26% |
| Dec 31, 2025 | 5.10B | -16.66% |
| Dec 31, 2024 | 6.12B | -2.25% |
| Dec 29, 2023 | 6.26B | -24.68% |
| Dec 30, 2022 | 8.32B | -7.87% |
| Dec 31, 2021 | 9.03B | 0.78% |
| Dec 22, 2021 | 8.96B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Lianhuan Pharmaceutical | 5.43B |
| Fuan Pharmaceutical (Group) | 5.34B |
| Zhejiang Yatai Pharmaceutical | 5.30B |
| Zhongzhu Healthcare Holding Co.,Ltd | 5.27B |
| Nanjing Hicin Pharmaceutical | 5.22B |
| Beijing Science Sun Pharmaceutical | 5.22B |
| Jianmin Pharmaceutical Group | 5.20B |
| Bide Pharmatech | 5.16B |